Related Experiment Videos
Pharmaceutical industry overview: optimal drug therapy.
1Bayer Inc, Healthcare Division, Etobicoke, Ontario, Canada. philip.blake.b@bayer.com
Summary
Genomics research is accelerating drug discovery, promising more therapeutic agents and personalized medicine. Disease management systems aim to optimize healthcare, improve patient outcomes, and control costs effectively.
Area of Science:
- Pharmacology
- Genomics
- Health Economics
Background:
- Genomics research is rapidly advancing drug discovery, with projections of a 15-fold increase in therapeutic agents over the next 10-20 years.
- Optimal drug therapy is becoming increasingly critical in healthcare due to these scientific advancements.
Purpose of the Study:
- To introduce a proposed therapeutic management system by Canada's Research-Based Pharmaceutical Companies.
- To outline a disease management approach focused on widespread, high-cost diseases for healthcare optimization and cost control.
Main Methods:
- The proposed system utilizes a disease management approach, comparing best practices with current care to identify adjustments for improved patient health and cost-effectiveness.
- Focuses on prevalent diseases with the highest healthcare system costs.
Main Results:
- Preliminary results from Canadian programs, such as in asthma treatment, indicate improvements in care quality.
- These initiatives represent a progressive step beyond cost-cutting measures alone.
Conclusions:
- Genomics-driven personalized medicine will introduce new challenges for drug plan policies and reimbursement.
- Optimal drug therapy can be significantly enhanced through personalized treatments and improved disease understanding, leading to better quality of life, saved lives, and healthcare cost savings.